MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Visuospatial-Visuoconstructive Alterations and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

J F. Ayala-Rico, C A. Hurtado-Gonzalez, S. Ospina-Otalvaro, J M. Márquez, L. Ortega-Bolaños, P A. Gutiérrez-Lenis, D A. Reyes-Torres, M I. Ortiz Agudelo, F. Rojas (Cali, Colombia)

Meeting: 2024 International Congress

Abstract Number: 498

Keywords: Parkinson’s, Scales

Category: Rating Scales

Objective: To identify whether depressive symptomatology in patients with IPDWD correlates with visuospatial and/or visuoconstructive alterations

Background: Visuospatial functioning and/or visuoconstructive skills are a cognitive domain that is often affected in IPDWD patients, associated with signs and symptoms of depression that contribute to the worsening of patients’ quality of life.

Method: The research presents a cross-sectional design, with a descriptive study type, the sample consists of a group of 50 patients diagnosed with IPDWD, with a mean age of 64.85 years and with an age younger than 12 years at diagnosis. For depressive symptomatology we used the ESDEPARK (Parkinson’s disease specific depression scale in the process of validation) and for visuospatial functioning, the Clock section of the Parkinson’s Disease Cognitive Rating Scale (PD-CRS).

Results: Preliminary results obtained by the ESDEPARK show that patients with PD-CRS present significant differences in the clock test section to the order (Rho= -.129; p= 037) and not to the copy (Rho= -0.28; p= ,652).

Conclusion: Preliminary results of the ESDEPARK IPDWD-specific depression scale show high consistency and reliability to identify visuospatial and visuoconstructive disturbances in patients with IPDWD.

To cite this abstract in AMA style:

J F. Ayala-Rico, C A. Hurtado-Gonzalez, S. Ospina-Otalvaro, J M. Márquez, L. Ortega-Bolaños, P A. Gutiérrez-Lenis, D A. Reyes-Torres, M I. Ortiz Agudelo, F. Rojas. Visuospatial-Visuoconstructive Alterations and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD. [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/visuospatial-visuoconstructive-alterations-and-depressive-symptomatology-in-patients-with-idiopathic-parkinsons-disease-without-dementia-ipdwd-preliminary-data-from-a-new-scale-specifically-for-m/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/visuospatial-visuoconstructive-alterations-and-depressive-symptomatology-in-patients-with-idiopathic-parkinsons-disease-without-dementia-ipdwd-preliminary-data-from-a-new-scale-specifically-for-m/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley